bit.bio

Description

bit.bio provides deterministically programmed human iPSC-derived cells and CRISPR screening services for research and drug discovery, offering ioCells catalogue products and custom cell development services.

bit.bio is located in the Cambridge ecosystem.

Related

• NucleraNuclera builds and supplies eProtein Discovery systems, cartridges, reagents and services for multiplex cell-free protein screening used by…
• OrganoTherapeuticsOrganoTherapeutics creates human iPSC-derived midbrain organoids, assembloids, and patient-specific Parkinson’s cell models, then provides…
• HealxHealx builds AI-driven drug discovery and development tools and therapies for rare disease patients, applying AI across discovery,…
• Cyted HealthCyted Health combines minimally invasive cell collection with molecular analysis to build diagnostic tests (EndoSign®) for earlier…
• 3H Biomedical3H Biomedical supplies primary human and animal cell-based products, RNA, DNA, assays and culture media for life science research, drug…
• OncolinesOncolines provides precision medicine services in oncology and cancer immunotherapy, offering cell‑based assays, profiling platforms,…
• ImmunAwareImmunAware supplies MHC class I molecules for custom monomers and tetramers, offers easYmers® to load peptides into custom peptide-MHC…
• AvectasAvectas develops the SoluScale cell engineering platform, combining a single-use SoluScale Cell Chamber and a compact automated…
• CaszymeCaszyme provides customized CRISPR solutions using a flexible platform and expertise in nucleases, mRNA, protein engineering, and evolution…